New England Journal of Medicine· 2013Q1· Review
Management of Antithrombotic Therapy in Patients Undergoing Invasive Procedures
- 465citations
- Q1SCImago
- 2013year
Short summary
Bridging anticoagulation with warfarin is recommended for patients undergoing invasive procedures who have a high risk of thrombosis, balancing bleeding and clotting risks.
AI-generated from the title and abstract; the full text is not read.
Key points
- Management of antithrombotic therapy in invasive procedures necessitates individual risk assessment for bleeding versus thrombosis.
- Bridging anticoagulation is a key consideration for patients on warfarin undergoing invasive procedures.
- The goal is to minimize both bleeding complications and thrombotic events.
AI-generated from the title and abstract; the full text is not read.
Abstract
When patients receiving anticoagulation therapy undergo invasive procedures, management requires an individualized assessment of the risk of bleeding versus the risk of thrombosis. This review explains management, including bridging anticoagulation for patients receiving warfarin.
The authors' abstract, as published at the source. New England Journal of Medicine, 2013 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Internal Medicine
Internal MedicineMedicine